SecBot SecBot

PEPG

PepGen Inc.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001835597 Biotech & Drug Discovery
$4.19 −0.17 (−3.90%)
Nov 16 4:00 PM ET · prev $4.36
Market cap
$475.1M
Small cap
Consensus
Buy
86% Buy or better · 14 analysts
Median target
$15.00
+258% · range $6.00–20.00
1 year
−21.7%
from $5.35 · Nov 17
30 days
+55.2%
from $2.70
52-week range
$1.35–7.17
−42% from high · low Jun 8
Avg volume 20D
8.02M
Nov 10 spike 106.52M
Short interest
3.37M
≈4.9% of shares · −11.5%
Days to cover
2.8
at average volume
Insider net
−$59.3K
0 buyers · 4 sellers · 12 mo
New fund stakes
0
Q3 2026 13F · 0 exits
Reddit crowd
50°
Neutral · 2 mentions this week
SecBot read BEARISH 4 reports · 90 days
Balance 3 bearish · 1 bullish oldest → newest, height = score
Avg score ·High conf. 3/4

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    4 insiders sold $59.3K.

  • InstitutionsMIXED

    Q3 2026: 12 added (0 new), 10 trimmed or exited.

  • AnalystsBULLISH

    12 of 14 rate it Buy or better. Every target is above the price.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.282 → −$0.312 over 90 days. 0 up, 1 down in 30 days.

  • Short sellersSTEADY

    Short interest −11.5% to 3.37M shares. 2.8 days to cover, ≈4.9% of shares.

  • TrendUPTREND

    49% above its 50-day average.

  • SocialQUIET

    Crowd 50° (neutral) this week from 2 mentions: 1 bullish, 1 bearish. No setup is alerting.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
MARSHALL WACE, LLPDOUBLED2,049,112$5.0M
RENAISSANCE TECHNOLOGIES LLCTRIM880,758$2.1M
JANE STREET GROUP, LLCADD296,712$718.0K
Connor, Clark & Lunn Investment Management Ltd.DOUBLED249,369$603.5K
Qube Research & Technologies LtdDOUBLED199,551$482.9K
DIMENSIONAL FUND ADVISORS LPDOUBLED181,151$438.1K
Squarepoint Ops LLCNEAR_EXIT117,215$283.7K
Quadrature Capital LtdADD56,641$137.1K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

14 analysts
Buy 86% rate it Buy or better
Strong Buy7Buy5Hold1Sell1Strong Sell0
12-month targets · 8 analysts

Price is below the lowest target. Median implies +258%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 13, 2026Guggenheim
MAINTAIN
MAINTAINBuy
Nov 11, 2026Wedbush
MAINTAIN
MAINTAINOutperform
Sep 9, 2026HC Wainwright & Co.
REITERATE
REITERATEBuy
Jun 16, 2026Craig-Hallum
INITIATE
INITIATEBuy
Reddit Mentions per day, 14 days
Crowd this week 50° Neutral 1 bullish · 1 bearish
Mentions, 7 days 2 1 in posts · 1 in comments
Recent posts
Recent comments
All social signals and their track records

Insider ledger

Form 4
$0
bought · 0 insiders
$59.3K
sold · 4 insiders
DateInsiderTypeValue
Jun 18, 2026
KEATING LAURIE
Director
Jun 18, 2026
AWARD34,000 sh
Jun 18, 2026
Dable Habib J
Director
Jun 18, 2026
AWARD34,000 sh
Jun 18, 2026
HENSON HEIDI
Director
Jun 18, 2026
AWARD34,000 sh
Jun 18, 2026
Finer Mitchell H.
Director
Jun 18, 2026
AWARD34,000 sh
Jun 18, 2026
Mayer Howard
Director
Jun 18, 2026
AWARD34,000 sh
Jun 18, 2026
Resnick Joshua
Director
Jun 18, 2026
AWARD34,000 sh
Jun 18, 2026
Wyman Lisa
Director
Jun 18, 2026
AWARD34,000 sh
Jun 18, 2026
RA CAPITAL MANAGEMENT, L.P.
Director
Jun 18, 2026
AWARD34,000 sh

Earnings setup

Estimates
−$0.27
EPS estimate, this quarter
−11%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.27-$0.29–-$0.26-1.6%$0.00
Next Q-$0.28-$0.32–-$0.22-10.0%$0.00
Current FY-$1.08-$1.20–-$1.00+2.0%$0.00
Next FY-$1.17-$1.78–-$0.81-10.7%$0.00

Short side

FINRA· Oct 30, 2026
3,367,041
shares short
-11.5%
vs prior settlement
2.8
days to cover
≈4.9%
of shares outstanding
Trading halts
Nov 10, 2026Resumption ScheduledResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 12, 2026 SEC
PepGen entered into an underwriting agreement for a $125 million public offering of 25 million shares at $5.00 per…
8-K · Impact 6/10
Nov 12, 2026 SEC
PepGen is offering 25,000,000 shares of common stock at $5.00 per share in a priced underwritten equity offering…
424B5 · Impact 6/10
Nov 10, 2026 SEC
PepGen is offering $125 million in common stock and pre-funded warrants via an underwritten takedown from its existing…
424B5 · Impact 6/10
Nov 10, 2026 Trading halt
Halt Resumed: PEPG, trading resumed after T3 (News and Resumption Times)
Halted 2026-11-10T11:56:00.000Z | Resumed 2026-11-10T12:30:00.000Z
Sep 30, 2026 Inst.
MARSHALL WACE, LLP · DOUBLED
2,049,112 shares ($5.0M)
Sep 30, 2026 Inst.
RENAISSANCE TECHNOLOGIES LLC · TRIM
880,758 shares ($2.1M)
Jun 18, 2026 Insider
KEATING LAURIE was granted 34,000 shares
Director
Jun 18, 2026 Insider
Dable Habib J was granted 34,000 shares
Director
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
1 drug tracked · Drug pipeline →
Recent

SecBot reports

12 filings · 2 bullish · 5 bearish · 1 mixed · 4 neutral
All PEPG filing & press-release reports (12)